Evan Seigerman analyst BMO

Currently, out of the existing stock ratings of Evan Seigerman - 101 which are a Buy (61.59%), 52 which are a Hold (31.71%), 11 which are a Sell (6.71%)

Evan Seigerman

Work Performance Price Targets & Ratings Chart

Analyst Evan Seigerman works at BMO and is covering the Healthcare sector with 364 price targets and ratings displayed on 20 stocks. Previously, Evan Seigerman worked at CREDIT SUISSE.

Evan Seigerman's average stock forecast success ratio is 63.67% with an average time for price targets to be met of 135.95 days.

Most recent stock forecast was given on NBIX, Neurocrine Biosciences at 13-Sep-2023.

Wall Street Analyst Evan Seigerman

Analyst best performing recommendations are on ACRX (ACELRX PHARMACEUTICALS).
The best stock recommendation documented was for ACRX (ACELRX PHARMACEUTICALS) at 3/24/2020. The price target of $20 was fulfilled within 1 day with a profit of $1 (5.26%) receiving and performance score of 52.63.

Average potential price target upside

ACRX AcelRx Pharmaceuticals AIMT AMGN Amgen BIIB Biogen BMY BristolMyers Squibb Company GILD Gilead Sciences GRTX Galera Therapeutics INCY yte LLY Eli Lilly and Company MRTX Mirati Therapeutics NBIX Neurocrine Biosciences PFE Pfizer REGN Regeneron Pharmaceuticals STSA Satsuma Pharmaceuticals VRTX Vertex Pharmaceuticals NUVB Nuvation Bio REPL Replimune Group CADL MGNX MacroGenics MRK Merck .

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$79.43 (13935.09%)


2 years 6 months 12 days ago

0/4 (0%)

$88.23 (131.84%)


2 years 10 months 22 days ago

3/3 (100%)

$1.27 (3.40%)




$119.43 (20952.63%)


4 years 4 months 19 days ago

0/6 (0%)

$69.05 (72.95%)



$179.43 (31478.95%)


4 years 10 months 23 days ago

0/4 (0%)

$65.23 (80.51%)



$159.43 (27970.18%)

4 years 11 months 13 days ago

1/5 (20%)

$78.22 (52.38%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Evan Seigerman is most bullish on?

Potential upside of $152.44 has been obtained for REGN (REGENERON PHARMACEUTICALS)

Which stock is Evan Seigerman is most reserved on?

Potential downside of -$10.23 has been obtained for MRTX (MIRATI THERAPEUTICS)

What Year was the first public recommendation made by Evan Seigerman?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart